Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients
NCT04366960
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
189
Enrollment
OTHER
Sponsor class
Conditions
Covid19
Interventions
DRUG:
Enoxaparin
Sponsor
Niguarda Hospital